India, Aug. 6 -- The Government of India has issued a release:
The Government recognizes that limited availability of validated human-relevant, non-animal models can affect the pace and efficiency of drug discovery and pre-clinical research, increase dependence on conventional animal studies and influence research costs and clinical translation. Laboratories across ministries namely, CSIR, ICMR and DBT are therefore promoting and strengthening use of advanced in-vitro, 3D tissue/organoid, cell-based and computational approaches for drug discovery, toxicity assessment and biomedical research. However, these methodologies currently complement, rather than fully replace, animal models, particularly for complex biological studies. The details are as below:
The Government recognizes the impact of limited availability of validated non-animal models on drug discovery, research costs and clinical translation. Accordingly, it continues to promote research, innovation, and capacity building for the development and adoption of such technologies in the country.
The Government continues to support research and innovation to develop non-animal testing methods to reduce dependence on conventional animal methods and enhance the efficiency of drug testing and preclinical research. The details are as below:
This information was given by the Minister of State (Ind. Charge) Science & Technology; Earth Sciences and Minister of State PMO; Personnel, Public Grievances and Pensions; Atomic Energy, Space Dr. Jitendra Singh in a written reply in Rajya Sabha today.
Disclaimer: Curated by HT Syndication.
